Vivimed Labs Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 26.73 | 34.24 | 22.19 |
| Operating Expense | 25.06 | 34.41 | 22.95 |
| Net Profit | -4.42 | -6.97 | -4.99 |
| Net Profit Margin | -16.54 | -20.36 | -22.49 |
| Earning Per Share | -0.53 | -0.84 | -0.60 |
| EBIDTA | 1.67 | -0.17 | -0.76 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 26.73 |
| Operating Expense | 25.06 |
| Net Profit | -4.42 |
| Net Profit Margin | -16.54 |
| Earning Per Share | -0.53 |
| EBIDTA | 1.67 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 136.80 | 176.83 | 218.37 |
| Operating Expenses Annual | 164.61 | 365 | 227.59 |
| Operating Profit Annual | -24.07 | -187.94 | -7.96 |
| Interest Annual | 1.90 | 35.28 | 39.53 |
| Depreciation | 16.09 | 15.38 | 15.20 |
| Net Profit Annual | -44.38 | -328.01 | -67.75 |
| Tax Annual | TBA | -2.12 | 2.82 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 136.80 |
| Operating Expenses Annual | 164.61 |
| Operating Profit Annual | -24.07 |
| Interest Annual | 1.90 |
| Depreciation | 16.09 |
| Net Profit Annual | -44.38 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.35 | 6.78 | 6.02 |
| Cash Flow from Operations | -96.52 | 32.87 | 25.31 |
| Cash Flow from Investing | 99.83 | -1.60 | -11.34 |
| Cash Flow from Financing | -5.51 | -34.70 | -13.21 |
| Cash Flow at the End | 1.14 | 3.35 | 6.78 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.35 |
| Cash Flow from Operations | -96.52 |
| Cash Flow from Investing | 99.83 |
| Cash Flow from Financing | -5.51 |
| Cash Flow at the End | 1.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -12.96 | -106.13 | -3.56 |
| PBIT Margin (%) | -26.42 | -166.59 | -11.55 |
| PBT Margin (%) | -15.46 | -161.90 | -11.26 |
| Net PROFIT Margin (%) | -32.44 | -185.49 | -31.03 |
| Return On Networth / Equity (%) | TBA | TBA | -14.96 |
| Return On Networth /Employed (%) | TBA | TBA | -2.60 |
| Return On Assets (%) | -6.81 | -38.95 | -6.83 |
| Total Debt / Equity (X) | 5.13 | 1.43 | 0.75 |
| Asset Turnover Ratio (%) | 0.21 | 0.21 | 0.22 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -12.96 |
| PBIT Margin (%) | -26.42 |
| PBT Margin (%) | -15.46 |
| Net PROFIT Margin (%) | -32.44 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -6.81 |
| Total Debt / Equity (X) | 5.13 |
| Asset Turnover Ratio (%) | 0.21 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 326.32 | 342.86 | 428.81 |
| Total Current Assets Annual | 275.72 | 271.16 | 441.82 |
| Non Current Assets Annual | 405.75 | 524.66 | 629.97 |
| Total Shareholders Funds Annual | 89.41 | 133.31 | 457.27 |
| Total Assets Annual | 681.47 | 795.82 | 1,071.79 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 326.32 |
| Total Current Assets Annual | 275.72 |
| Non Current Assets Annual | 405.75 |
| Total Shareholders Funds Annual | 89.41 |
| Total Assets Annual | 681.47 |
EPS (INR)
Expected
0.00
Reported
-0.68
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
